Objectives: Since melioidosis mimics tuberculosis clinically and radiologically, there is a need for a rapid diagnostic method to help the clinician to initiate appropriate antimicrobial treatment in order to prevent mortality. Our objective was to standardize a nested PCR for B. pseudomallei and its detection in pulmonary and extra pulmonary samples from patients with suspected TB.
INTRODUCTION
Burkholderia pseudomallei is a facultative gram negative organism, opportunistic and intracellular pathogen. It can present with latent disease manifestations similar to Mycobacterium tuberculosis. Melioidosis may occur as a subclinical infection or as localized infection such as abscess, granuloma, pneumonia, meningoencephalitis, sepsis, chronic suppurative infection which can progress to a gram negative septicemia resulting in a multi-organ failure. B. pseudomallei thrive well in damp climate and terrain of flooded low-lying plains. Most of the endemic regions include the rice growing regions of South East Asian countries [1, 2] . Risk factors like diabetes mellitus, alcoholism, renal disease, chronic liver disease, steroid therapy and malignancy are considered responsible for reactivation and disease progression [3, 4] . Routine diagnostic methods include culture of the organism from blood, sputum, pus, urine, synovial fluid, peritoneal fluid, and pericardial fluid. Molecular assays are available only at reference laboratories in endemic countries. Mortality can be prevented by a timely detection and treatment with specific antibacterial agents [5] .
METHODS

Patient selection criteria
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A retrospective study was conducted to determine the presence of B. pseudomallei by nested PCR. Patients presenting with persistent cough, fever, weight loss, loss of appetite and other signs and symptoms consistent with tuberculosis but negative for AFB smear microscopy, culture & PCR were included in the study. Samples of patients from specialty clinics were considered as low index of suspicion for tuberculosis based on their clinical signs and symptoms consistent with tuberculosis such as fever ,cough, loss of weight, loss of appetite >3 weeks duration [6, 7] . Similarly, patients from the RNTCP center were considered as high index of suspicion for tuberculosis [6, 7] . Institutional ethics committee approval was obtained (IEC Ref No: IEC-NI/09/DEC/13/39) and informed consent was obtained from patients prior to sample collection. The samples collected were stored at -20° C in multiple aliquots. Clinical details were collected both retrospectively and prospectively.
Nested PCR
A conventional nested PCR for B. pseudomallei was done on 36 sputum samples from patients suspected to have tuberculosis and 19 pus samples from patients with suspected extra pulmonary tuberculosis. DNA extraction was performed as per the manufacturer's instructions (Qiagen, Germany). DNA extraction was done using lysis buffer after addition of proteinase-K and incubated for 30 minutes at 56 o C. The lysed DNA was then precipitated using ethanol and purified with wash buffers. The DNA was eluted and stored at -20 ˚C.
A nested PCR was performed targeting the 16S-23S spacer region [8] . The primer details are listed in Table 1 [8, 9] . The cycling conditions for the first round PCR were 95 °C for 15 min, 30 cycles of 95 °C for 45 s, 52 °C for 40 s, 72 °C for 1 min, and 72 °C for 7 min. The cycling conditions for the second round PCR were 95 °C for 5 min, 30 cycles of 95 °C for 30 s, 60°C for 30 s, 72 °C for 45 s, and 72 °C for 7 min. Two microliter of first product was used as a template for the second round. The second round PCR amplicons were subjected to 2 % agarose gel electrophoresis and were analyzed under Gel documentation unit (BIORAD). The band size of 251 bp was considered positive for 16S-23S spacer region [8] . B. pseudomallei plasmid DNA was used as positive control for detection of B. pseudomallei. To avoid PCR carry-over contamination appropriate measures were taken which includes use of negative control (Sterile Milli-Qwater) between every three samples. The study results were checked for inter-reader reproducibility. The test samples which were repeatedly positive were considered positive to insure reproducibility.
Automated Culture
The samples that were positive for the above nested PCR were subjected to automated culture identification using VITEK-2 system [10] .
RESULTS
A total of 55 samples were included in this study. Of these, 36 (65.45%) were collected from patients attending specialty clinics and the remaining 19 (34.54%) were collected from patients attending RNTCP center. The overall samples included consist of 19 (34.54%) pus samples and 36 (65.45%) sputum samples; in high index of suspicion group all 19 (34.54%) were sputum samples.
A total of 9 (16%) samples were found to be positive for B. pseudomallei (n=55) by nested PCR (Figure 1 and 2), out of which 4 (44%) were sputum samples and 5 (56%) were pus samples. All nine samples tested negative for AFB by microscopy and negative for M. tuberculosis by PCR targeting IS6110 and TRC4 region (Figure 3a and 3b). The samples (pus) that were positive by PCR were negative for growth by culture. Analysis of demographic profile of the patients positive for B. pseudomallei (n=9) showed mean age to be 45 years and the male / female ratio was 1.25:1. Geographically, most of them belonged to Tamil Nadu which includes 8 (89%) patients but one (11%) to West Bengal. Among the patients who were positive for B. pseudomallei by the nested PCR, 7 (78%) attended specialty clinics (low index of suspicion for tuberculosis), out of which 5 (56%) were extra pulmonary samples (pus) and 2 (22%) were pulmonary samples. Similarly, among the patients who were positive for B. pseudomallei, two (22%) attended the RNTCP center (high index of suspicion for tuberculosis). Clinical profiles of the 9 (16%) patients who were positive for B. pseudomallei are shown in the table 2 and  table 3 . In the 5 (56%) patients who had extrapulmonary manifestations, the common clinical manifestations observed were site specific pain in 3 (33%) patients, followed by chronic loss of weight in 2 (22%) and persistent fever in one (11%) patient. In this group the major co-morbid conditions encountered were the presence of chronic kidney disease in 2 (22%) patients, malignancy and diabetes mellitus each in one (11%) patient. Also, among patients in low index of suspicion group who were positive for B. pseudomallei by nested PCR, 2 (22%) were receiving empirical Anti-tubercular treatment (ATT).
In patients with pulmonary manifestations (n=4), persistent cough and fever were the most common clinical manifestations found among 3 (33%) patients, followed by chronic loss of weight, loss of appetite and/or breathlessness in 2 (22%) patients. They also presented with comorbid conditions such as chronic kidney disease, malignancy, HIV infection, and alcoholism each in one patient. 
DISCUSSION
Melioidosis is a potentially fatal infectious disease endemic in Southeast Asia; it has been reported to be under diagnosed in India [11] . After the 2004 Southeast Asian tsunami, an increase in the number of melioidosis cases was observed in these areas [8] . Also, the incidence of melioidosis in tropical countries has generally increased as there is an increase in immune compromised especially people with diabetes mellitus and renal disease [1, 12] . In our study, co-morbid conditions encountered include chronic kidney disease (n=3), malignancy (n=2), diabetes mellitus (n=1), HIV infection (n=1) and alcoholism (n=1). These co-morbidities have been previously reported in melioidosis [1, 12] .
Pulmonary condition like pneumonia is a common manifestation of B. pseudomallei. Subacute pneumonia or chronic pneumonia with low grade fever may be mistaken for pulmonary tuberculosis. Melioidosis can also present as an organ specific or localized disease such as intraabdominal abscess [13, 14] . We found that out of the five pus samples positive for B. pseudomallei, 3(33%) were from patients who had deep seated abscess of which two were in the psoas region and one was a renal abscess, the rest included one patient with a pancreatic abscess and a chest wall abscess.
In our study, B. pseudomallei was detected in 9 (16%) samples from patients suspected to be having pulmonary tuberculosis as well as extra pulmonary tuberculosis. These nine samples tested negative for smear microscopy and PCR for M. tuberculosis targeting IS6110 & TRC4 region. Further, 19(34.54%) samples from the high index of suspicion group were also confirmed to be negative for M. tuberculosis by culture method (Lowenstein Jensen (LJ) media). To detect M. tuberculosis a combination of laboratory methods such as microscopy, culture are required. Smear microscopy is rapid and easy to perform but has been reported to have lower sensitivity when compared to culture. Culture method though considered as gold standard, they are time consuming and requires sophisticated laboratories [15, 16] . Often in TB endemic areas, empirical ATT may be started in the absence of any laboratory evidence.
Among the PCR positives, we have subjected the 5 pus samples to culture using VITEK-2 system. None of these samples showed growth on culture. Since all the patients had prior exposure to antibiotics for persistent fever, this could account for 'no growth in culture' [8, 17] . We have documented culture negativity in pus samples. This has been reported in another study from South India, where blood culture was reported negative due to low bacterial load [8, 9] . It has also been reported that often the identity of B. pseudomallei is by PCR method and the reason could be due to increased accuracy of the nested PCR targeting the 16S-23S rRNA spacer region (limit of detection: 1 colony forming unit/ 5µL PCR reaction for B. pseudomallei) [8, 9] . In the case of sputum samples, we did not have enough material to do culture. This is because, earlier we did multiple tests with the sputum samples such as AFB smear microscopy, culture (using LJ medium) and PCR for TB targeting IS6110 and TRC4 region (a part of another study).
Identification of B. pseudomallei by culture using selective medium such as Ashdown's medium, requires minimum of 48-72 hours for identifica- Contamination in PCR is likely to remain problematic. However measures to ensure quality control and quality assurance are routinely followed in the laboratory [19] . We have carried out the work in a dedicated PCR laboratory where culture or multiple assays are not done. As a good laboratory practice, we maintain use of three room set-up, dedicated instruments and sterile consumables [19, 20] . Reagents were handled inside laminar flow hood, where we prepare and aliquot reagent mix into PCR tubes. Later, these tubes were opened only once to add DNA inside a bio-safety cabinet. These work areas are cleaned with DNase away and subjected to UV sterilization as per standard operating procedure (SOP). Gloves were changed between additions of each DNA and disposable sterile tips with filter (barrier) were used to ensure no sample to sample contamination. Consumables, instruments and protective clothing used in the processing area were not taken back into the reagent preparation area. Thus, the unidirectional work flow was maintained. To ensure no amplification error, we have included positive control and followed optimal cycling conditions for each run. To identify any cross-contamination or carry-over contamination, we have included negative controls between every three samples and reagent control or no template control to identify reagent contamination if any [19, 20] . We believe in the integrity of the PCR test result since these quality measures have been strictly followed. In our study, to ensure the reliability of the PCR positive results the positive samples were repeatedly tested by two persons (EJ & RB). We therefore believe that there was no scope for false positivity due to carry-over contamination or crosscontamination in our results. Previous reports suggest that the primers targeting 16S-23S spacer region to be highly sensitive and specific as it did not amplify or cross-react with other heterologous targets [8, 9] .
We performed PCR on samples obtained from patients with specific signs and symptoms of tuberculosis such as persistent cough and fever, chronic loss of weight, loss of appetite, breathlessness and site specific pain (Table 2 & 3) . Patients who present with fever for prolonged duration are usually treated as TB, because TB is endemic; B. pseudomallei may not be looked for. We have identified B. pseudomallei DNA in 9 patients (five pus and four sputum samples) who were clinically suggestive of melioidosis [21] [22] [23] . To prevent misdiagnosis and for initiation of appropriate therapy as well as avoiding unnecessary exposure to anti-tubercular drugs we suggest to carryout screening for B. pseudomallei by PCR tests in patients who have signs and symptoms suggestive of tuberculosis.
Demographic analysis of all nine patients diagnosed as melioidosis has shown that all patients belong either to Tamil Nadu or West Bengal, states known for the cultivation of rice (Table 2 &  3) . We also found in our study that out of the nine patients who were positive for B. pseudomallei by nested PCR, two patients presented to RNTCP center as they had symptoms highly suggestive of tuberculosis and the remaining seven patients presented to different specialties clinics like Nephrology, Orthopedic, Obstetrics and Gynecology, General Surgery and General medicine suggesting the varied clinical presentation of melioidosis. To our knowledge this is the first study to document the presence of B. pseudomallei in patients with low and high index for suspicion of tuberculosis. We suggest that in 
